Literature DB >> 1265354

Experimentally produced calf pneumonia.

R N Gourlay, C J Howard, L H Thomas, E J Stott.   

Abstract

Experimental pneumonia was produced in calves by the endobronchial inoculation of pneumonic lung homogenates. Irradiated homogenates produced minimal pneumonia. Ampicillin treatment of the homogenates and the experimental calves reduced the extent of pneumonia. Treatment with tylosin tartrate prevented experimental pneumonia. These results suggest that the total pneumonia was due to organisms susceptible to tylosin tartrate and that the residual pneumonia remaining after ampicillin treatment was due to organisms susceptible to tylosin tartrate but not to ampicillin. Of the organisms isolated from the lungs, the ones in this latter category most likely to be responsible are Mycoplasma dispar and ureaplasmas (T-mycoplasmas).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1265354

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  5 in total

1.  Ureaplasmal epithelial lesions related to ammonia.

Authors:  O H Stalheim; J E Gallagher
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

2.  Isolation of Ureaplasma from bovine granular vulvitis.

Authors:  H L Ruhnke; P A Doig; A L MacKay; A Gagnon; M Kierstead
Journal:  Can J Comp Med       Date:  1978-04

3.  Interaction of Mycoplasma dispar and Mycoplasma agalactiae subsp. bovis with bovine alveolar macrophages and bovine lacteal polymorphonuclear leukocytes.

Authors:  C J Howard; G Taylor; J Collins; R N Gourlay
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

4.  The incidence of Mycoplasma dispar, Ureaplasma and conventional Mycoplasma in the pneumonic calf lung.

Authors:  O A Muenster; E E Ose; T Matsuoka
Journal:  Can J Comp Med       Date:  1979-10

5.  A search for new microorganisms in calf pneumonia by the inoculation of gnotobiotic calves.

Authors:  L H Thomas; R N Gourlay; E J Stott; C J Howard; J C Bridger
Journal:  Res Vet Sci       Date:  1982-09       Impact factor: 2.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.